{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:34:02Z","timestamp":1773308042802,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The role of B Lymphocyte Stimulator (BLyS) in the survival of malignant B cells and the maintenance of normal B cell development and homeostasis has been intensively studied in the literature. However, the influence of BLyS on breast cancer progression remains unclear. The study aimed to investigate the effect of hypoxia on BLyS regulation, cell migratory response to BLyS and the possible molecular mechanisms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this study, we examined the role of BLyS in the migration of human breast cancer cells by transwell assay. We also explored whether BLyS and its receptors expressed in human breast cancer cell lines by immunofluorescence and Western Blotting. Then we detected the expression level of BLyS in both normoxic and hypoxic conditions by real time-PCR and Western Blotting. Pathways involved were confirmed by Western Blotting, immunofluorescence, transwell assay and luciferase assay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>According to our study, the expression level of BlyS was increased in human breast cancer cell lines in hypoxic conditions. Up-regulation of this protein led to activation and nuclear translocation of NF-kappa B p65. We also found that the number of migrated cells was increased in the presence of BLyS and inhibition of phosphorylation of Akt attenuated the enhanced migratory response.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>It suggested that better understanding of BLyS, an immunopotentiator, may offer a potential therapeutic target for the treatment of human breast cancers. In addition, BLyS promoted breast cancer cells migration, underscoring the necessity of appropriate applications of immunopotentiators to cancer treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1756-9966-31-31","type":"journal-article","created":{"date-parts":[[2012,3,31]],"date-time":"2012-03-31T12:13:50Z","timestamp":1333196030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["BlyS is up-regulated by hypoxia and promotes migration of human breast cancer cells"],"prefix":"10.1186","volume":"31","author":[{"given":"Jing","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sensen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongdong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenting","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengtao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,31]]},"reference":[{"key":"565_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.smim.2006.06.001","volume":"18","author":"RT Woodland","year":"2006","unstructured":"Woodland RT, Schmidt MR, Thompson CB: BLyS and B cell homeostasis. Semin Immunol. 2006, 18: 318-326. 10.1016\/j.smim.2006.06.001.","journal-title":"Semin Immunol"},{"key":"565_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.smim.2006.04.004","volume":"18","author":"SG Tangye","year":"2006","unstructured":"Tangye SG, Bryant VL, Cuss AK, Good KL: BAFF, APRIL and human B cell disorders. Semin Immunol. 2006, 18: 305-317. 10.1016\/j.smim.2006.04.004.","journal-title":"Semin Immunol"},{"key":"565_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1182\/blood-2003-06-2043","volume":"103","author":"AJ Novak","year":"2004","unstructured":"Novak AJ, Darce JR, Arendt BK, Harder B, Henderson K, Kindsvogel K, Gross JA, Greipp PR, Jelinek DF: Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood. 2004, 103: 689-694. 10.1182\/blood-2003-06-2043.","journal-title":"Blood"},{"key":"565_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.clim.2008.12.009","volume":"131","author":"R Parameswaran","year":"2009","unstructured":"Parameswaran R, David HB, Sharabi A, Zinger H, Mozes E: B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus. Clin Immunol. 2009, 131: 223-232. 10.1016\/j.clim.2008.12.009.","journal-title":"Clin Immunol"},{"key":"565_CR5","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.smim.2006.06.002","volume":"18","author":"SL Kalled","year":"2006","unstructured":"Kalled SL: Impact of the BAFF\/BR3 axis on B cell survival, germinal center maintenance and antibody production. Semin Immunol. 2006, 18: 290-296. 10.1016\/j.smim.2006.06.002.","journal-title":"Semin Immunol"},{"key":"565_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1471-2407-8-76","volume":"8","author":"V Pelekanou","year":"2008","unstructured":"Pelekanou V, Kampa M, Kafousi M, Darivianaki K, Sanidas E, Tsiftsis DD, Stathopoulos EN, Tsapis A, Castanas E: Expression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas. BMC Cancer. 2008, 8: 76-10.1186\/1471-2407-8-76.","journal-title":"BMC Cancer"},{"key":"565_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1055\/s-0030-1255355","volume":"30","author":"O Rosmorduc","year":"2010","unstructured":"Rosmorduc O, Housset C: Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease. Semin Liver Dis. 2010, 30: 258-270. 10.1055\/s-0030-1255355.","journal-title":"Semin Liver Dis"},{"key":"565_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0006-291X(03)01073-8","volume":"306","author":"HJ Jeong","year":"2003","unstructured":"Jeong HJ, Chung HS, Lee BR, Kim SJ, Yoo SJ, Hong SH, Kim HM: Expression of proinflammatory cytokines via HIF-1alpha and NF-kappa B activation on desferrioxamine-stimulated HMC-1 cells. Biochem Biophys Res Commun. 2003, 306: 805-811. 10.1016\/S0006-291X(03)01073-8.","journal-title":"Biochem Biophys Res Commun"},{"key":"565_CR9","first-page":"146","volume":"45","author":"M Yan","year":"2010","unstructured":"Yan M, He D, Zhang P, Zhou XJ, Chen WT: Inflammatory factors promote oral squamous cell carcinoma cells metastasis, via nuclear factor kappa B signal pathway in vitro. Zhonghua Kou Qiang Yi Xue Za Zhi. 2010, 45: 146-151.","journal-title":"Zhonghua Kou Qiang Yi Xue Za Zhi"},{"key":"565_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ejphar.2010.09.065","volume":"650","author":"G Huang","year":"2011","unstructured":"Huang G, Yang Y, Xu Z, Zhou P, Gong W, Li Y, Fan J, He F: Downregulation of B lymphocyte stimulator expression by curcumin in B lymphocyte via suppressing nuclear translocation of NF-kappa B. Eur J Pharmacol. 2011, 650: 451-457. 10.1016\/j.ejphar.2010.09.065.","journal-title":"Eur J Pharmacol"},{"key":"565_CR11","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","volume":"189","author":"S Pascal","year":"1999","unstructured":"Pascal S, Fabienne M, Veronique S, Kay H, Jean LB, Nils H, Christine A, Pornsri L, Sarah B, Hans AO, Danila V, Pedro R, Christiane WF, Rudolph HZ, Jeffrey LB, Jurg T: BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med. 1999, 189: 1747-1758. 10.1084\/jem.189.11.1747.","journal-title":"J Exp Med"},{"key":"565_CR12","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0006-2952(03)00493-3","volume":"66","author":"MK Geertruida","year":"2003","unstructured":"Geertruida MK, Berengere PB, Michael H, Jan PM: TWE-PRIL: a fusion protein of TWEAK and APRIL. Biochem Pharmacol. 2003, 66: 1427-1432. 10.1016\/S0006-2952(03)00493-3.","journal-title":"Biochem Pharmacol"},{"key":"565_CR13","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1182\/blood-2008-10-183467","volume":"113","author":"L Fu","year":"2009","unstructured":"Fu L, Lin-Lee YC, Pham LV, Tamayo AT, Yoshimura LC, Ford RJ: BAFF-R promotes cell proliferation and survival through interaction with IKK-beta and NF-kappa B\/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells. Blood. 2009, 113: 4627-4636. 10.1182\/blood-2008-10-183467.","journal-title":"Blood"},{"key":"565_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.arr.2007.09.002","volume":"7","author":"A Salminen","year":"2008","unstructured":"Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T: Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing Res Rev. 2008, 7: 83-105. 10.1016\/j.arr.2007.09.002.","journal-title":"Ageing Res Rev"},{"key":"565_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.yexmp.2003.10.005","volume":"76","author":"KM Mohamed","year":"2004","unstructured":"Mohamed KM, Le A, Duong H, Wu Y, Zhang Q, Messadi DV: Correlation between VEGF and HIF-1alpha expression in human oral squamous cell carcinoma. Exp Mol Pathol. 2004, 76: 143-152. 10.1016\/j.yexmp.2003.10.005.","journal-title":"Exp Mol Pathol"},{"key":"565_CR16","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jhep.2010.01.018","volume":"52","author":"E Villa","year":"2010","unstructured":"Villa E, Fattovich G: No inflammation? No cancer! Clear HBV early and live happily. J Hepatol. 2010, 52: 768-770. 10.1016\/j.jhep.2010.01.018.","journal-title":"J Hepatol"},{"key":"565_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1158\/1541-7786.MCR-05-0261","volume":"4","author":"H Lu","year":"2006","unstructured":"Lu H, Ouyang WM, Huang CS: Inflammation, a key event in cancer development. Mol Cancer Res. 2006, 4: 221-233. 10.1158\/1541-7786.MCR-05-0261.","journal-title":"Mol Cancer Res"},{"key":"565_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","volume":"17","author":"N Erez","year":"2010","unstructured":"Erez N, Truitt M, Olson P, Arron ST, Hanahan D: Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappa B-Dependent Manner. Cancer Cell. 2010, 17: 135-147. 10.1016\/j.ccr.2009.12.041.","journal-title":"Cancer Cell"},{"key":"565_CR19","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.coph.2010.08.003","volume":"10","author":"K Hinohara","year":"2010","unstructured":"Hinohara K, Gotoh N: Inflammatory signaling pathways in self-renewing breast cancer stem cells. Curr Opin Pharmacol. 2010, 10: 650-654. 10.1016\/j.coph.2010.08.003.","journal-title":"Curr Opin Pharmacol"},{"key":"565_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/emmm.200900043","volume":"1","author":"JM Lopez-Novoa","year":"2009","unstructured":"Lopez-Novoa JM, Nieto MA: Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med. 2009, 1: 303-314. 10.1002\/emmm.200900043.","journal-title":"EMBO Mol Med"},{"key":"565_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2004.07.013","volume":"118","author":"RG Florian","year":"2004","unstructured":"Florian RG, Tim FG, Jin MP, Li ZW, Laurence JE, Martin FK, Michael K: IKK\u03b2 links inflammation and tumotigensis in a mouse model of colitis-associated cancer. Cell. 2004, 118: 285-296. 10.1016\/j.cell.2004.07.013.","journal-title":"Cell"},{"key":"565_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.ejso.2004.10.010","volume":"31","author":"YY Yu","year":"2005","unstructured":"Yu YY, Li Q, Zhu ZG: NF-kappa B as a molecular target in adjuvant therapy of gastrointestinal carcinomas. Eur J Surg Oncol. 2005, 31: 386-392.","journal-title":"Eur J Surg Oncol"},{"key":"565_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mce.2009.10.010","volume":"321","author":"F Pacifico","year":"2009","unstructured":"Pacifico F, Leonardi A: Role of NF-\u03baB in thyroid cancer. Mol Cell Endocrinol. 2009, 321: 29-35.","journal-title":"Mol Cell Endocrinol"},{"key":"565_CR24","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.cellsig.2010.05.003","volume":"22","author":"RR Gonzalez-Perez","year":"2010","unstructured":"Gonzalez-Perez RR, Xu Y, Guo S, Watters A, Zhou W, Leibovich SJ: Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappa B\/HIF-1alpha activation. Cell Signal. 2010, 22: 1350-1362. 10.1016\/j.cellsig.2010.05.003.","journal-title":"Cell Signal"},{"key":"565_CR25","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.bbrc.2007.05.125","volume":"359","author":"J Mi","year":"2007","unstructured":"Mi J, Zhang X, Liu Y, Reddy SK, Rabbani ZN, Sullenger BA, Clary BM: NF-kappa B inhibition by an adenovirus expressed aptamer sensitizes TNFalpha-induced apoptosis. Biochem Biophys Res Commun. 2007, 359: 475-480. 10.1016\/j.bbrc.2007.05.125.","journal-title":"Biochem Biophys Res Commun"},{"key":"565_CR26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.steroids.2009.02.003","volume":"74","author":"AM Scherbakov","year":"2009","unstructured":"Scherbakov AM, Lobanova YS, Shatskaya VA, Krasil'nikov MA: The breast cancer cells response to chronic hypoxia involves the opposite regulation of NF-kB and estrogen receptor signaling. Steroids. 2009, 74: 535-542. 10.1016\/j.steroids.2009.02.003.","journal-title":"Steroids"},{"key":"565_CR27","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1182\/blood-2004-02-0762","volume":"104","author":"AJ Novak","year":"2004","unstructured":"Novak AJ, Grote DM, Stenson M, Ziesmer SC, Witzig TE, Habermann TM, Harder B, Ristow KM, Bram RJ, Jelinek DF, Gross JA, Ansell SM: Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood. 2004, 104: 2247-2253. 10.1182\/blood-2004-02-0762.","journal-title":"Blood"},{"key":"565_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbrc.2010.06.043","volume":"398","author":"CH Ryu","year":"2010","unstructured":"Ryu CH, Park SA, Kim SM, Lim JY, Jeong CH, Jun JA, Oh JH, Park SH, Oh WI, Jeun SS: Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1\/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways. Biochem Biophys Res Commun. 2010, 398: 105-110. 10.1016\/j.bbrc.2010.06.043.","journal-title":"Biochem Biophys Res Commun"},{"key":"565_CR29","doi-asserted-by":"publisher","first-page":"e16477","DOI":"10.1371\/journal.pone.0016477","volume":"6","author":"C Gamell","year":"2011","unstructured":"Gamell C, Susperregui AG, Bernard O, Rosa JL, Ventura F: The p38\/MK2\/Hsp25 pathway is required for BMP-2-induced cell migration. PLoS One. 2011, 6: e16477-10.1371\/journal.pone.0016477.","journal-title":"PLoS One"},{"key":"565_CR30","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1084\/jem.20060990","volume":"203","author":"A Patke","year":"2006","unstructured":"Patke A, Mecklenbrauker I, Erdjument-Bromage H, Tempst P, Tarakhovsky A: BAFF controls B cell metabolic fitness through a PKC beta- and Akt-dependent mechanism. J Exp Med. 2006, 203: 2551-2562. 10.1084\/jem.20060990.","journal-title":"J Exp Med"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-31-31.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:56:17Z","timestamp":1630522577000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-31-31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,31]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["565"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-31-31","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,31]]},"assertion":[{"value":"6 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"31"}}